FCM
COLL icon

Firestone Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Firestone Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-600
Closed -$12K – 461
2020
Q3 		$12K Hold
600
– – 0.01% 305
2020
Q2 		$11K Hold
600
– – 0.01% 315
2020
Q1 		$10K Sell
600
-150
-20% -$3.1K 0.01% 309
2019
Q4 		$15K Buy
+750
New +$12.5K 0.01% 319

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Firestone Capital Management's COLL Position: Q4 2020 in Review

Firestone Capital Management sold out of Collegium Pharmaceutical (COLL) in Q4 2020, closing a stake of 600 shares — an estimated $12K sold.

Firestone Capital Management first reported a position in COLL in Q4 2019 and held it in 4 quarters. The position peaked at $15K in Q4 2019. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2020.

  • Firestone Capital Management reported no remaining Collegium Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Firestone Capital Management sold 600 Collegium Pharmaceutical shares in Q4 2020, an estimated $12K.
  • Firestone Capital Management first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 4 quarters.
  • Firestone Capital Management's Collegium Pharmaceutical position peaked at $15K in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2020.

Based on Firestone Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.